CLEARSIDE DEVELOPED PROGRAMS
THERAPEUTIC
TYPE
INDICATION
CURRENT STATUS / PARTNER
THERAPEUTIC, TYPE, INDICATION, STATUS, PARTNER
XIPERE® / ARCATUS™
Corticosteroid (Triamcinolone Acetonide)
Uveitic Macular Edema2
(Asia Pacific ex-Japan)
![pipeline-graphics-10](https://clearsidebio.com/wp-content/uploads/2023/12/pipeline-graphics-10-scaled.jpg)
![logo-arctic-vision](https://clearsidebio.com/wp-content/uploads/2021/09/logo-arctic-vision.png)
XIPERE® / ARCATUS™
Corticosteroid (Triamcinolone Acetonide)
Diabetic Macular Edema2
(Asia Pacific ex-Japan)
![pipeline-graphics-dme](https://clearsidebio.com/wp-content/uploads/2024/01/pipeline-graphics-dme.jpg)
![logo-arctic-vision](https://clearsidebio.com/wp-content/uploads/2021/09/logo-arctic-vision.png)
SCS Microinjector® Partner Clinical Development Programs
THERAPEUTIC
TYPE
INDICATION
CURRENT STATUS / PARTNER
THERAPEUTIC, TYPE, INDICATION, STATUS, PARTNER
Bel-Sar
Viral-like Drug Conjugate
Choroidal Melanoma
![pipeline-graphics-12](https://clearsidebio.com/wp-content/uploads/2023/12/pipeline-graphics-12-scaled.jpg)
![aura-logo](https://clearsidebio.com/wp-content/uploads/2023/12/aura-logo.jpg)
ABBV-RGX-314
AAV Gene Therapy
Diabetic Retinopathy
![pipeline-graphics-13](https://clearsidebio.com/wp-content/uploads/2023/12/pipeline-graphics-13-scaled.jpg)
![regenexbio-abbvie](https://clearsidebio.com/wp-content/uploads/2023/12/regenexbio-abbvie.jpg)
ABBV-RGX-314
AAV Gene Therapy
Wet AMD
![pipeline-graphics](https://clearsidebio.com/wp-content/uploads/2023/12/pipeline-graphics-scaled.jpg)
![regenexbio-abbvie](https://clearsidebio.com/wp-content/uploads/2023/12/regenexbio-abbvie.jpg)
Avoralstat
Plasma Kallikrein Inhibitor
Diabetic Macular Edema
![pipeline-graphics-15](https://clearsidebio.com/wp-content/uploads/2023/12/pipeline-graphics-15-scaled.jpg)
![bio-cryst](https://clearsidebio.com/wp-content/uploads/2023/12/bio-cryst.jpg)
Footnotes:
1XIPERE® (triamcinolone acetonide injectable suspension), for suprachoroidal use has received U.S. FDA Approval and is being commercialized by Bausch + Lomb.
2In China, Arctic Vision is responsible for clinical development of ARCATUS™ (triamcinolone acetonide injectable suspension), formerly referred to as ARVN001, and known as XIPERE® in the U.S.